TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer.
about
Recombinant human adenovirus-p53 therapy for the treatment of nasopharyngeal carcinoma: a meta-analysisP53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer.Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors.Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancerSynergistic cytotoxic effects of recombinant human adenovirus p53 and radiation at various time points in A549 lung adenocarcinoma cells.Immunohistochemical evaluation of cell cycle regulators: impact on predicting prognosis in stage t1 urinary bladder cancer.The Prognostic Impact of p53 Expression on Sporadic Colorectal Cancer Is Dependent on p21 StatusTP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.Adjuvant therapy for rectal cancerMechanisms of resistance to ionizing radiation in rectal cancer.Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.Human tumor cells segregate into radiosensitivity groups that associate with ATM and TP53 status.TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling.Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.National cancer database analysis of outcomes in pediatric glioblastoma.P53 abnormalities and outcomes in colorectal cancer: a systematic review
P2860
Q28071453-D9512994-922C-4BC5-949C-A2194B3597A1Q34438092-94243D23-4FBF-450D-A390-02A996AE7FB5Q34599442-68B91358-2E27-4FB4-908F-E6397F3052C2Q35460703-2A72C17B-AE4F-49C6-821C-07FF4855BD0EQ36225859-D7E9F075-DDCB-4F1B-8117-AF5706061DFCQ36470349-FF30DEE9-08F9-4673-B27D-D8754DC95D53Q37129876-56F64244-1C21-4AB8-8FFB-FAC4DB671CA2Q37362747-4F5BC861-52B6-4E54-A932-F6972700E00EQ37462241-B2A0A5C9-D3B8-4E11-BAE9-F18331CD25C2Q37542265-A743C33C-893C-4730-A080-A318CAE2CB33Q38623990-92758164-4FF2-4259-B8AA-15CD99CCA2E3Q40121119-406DF0DB-A8D0-446F-A569-5B69B5B8EF84Q41733541-22033ACE-2408-4C89-A972-53BFBFCD7CD9Q47801747-FD077B7B-F4E1-4999-9841-C861DEDB0CF6Q50173842-8661749F-D660-4440-8E7D-AE88441E3923Q55277149-DDFD8404-6F45-4017-952E-2F688A9749DDQ57522029-982910B4-0BF2-4F5E-BB91-C4844B593A87
P2860
TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
TP53 genotype but not p53 immu ...... radiotherapy in rectal cancer.
@ast
TP53 genotype but not p53 immu ...... radiotherapy in rectal cancer.
@en
type
label
TP53 genotype but not p53 immu ...... radiotherapy in rectal cancer.
@ast
TP53 genotype but not p53 immu ...... radiotherapy in rectal cancer.
@en
prefLabel
TP53 genotype but not p53 immu ...... radiotherapy in rectal cancer.
@ast
TP53 genotype but not p53 immu ...... radiotherapy in rectal cancer.
@en
P2093
P1433
P1476
TP53 genotype but not p53 immu ...... radiotherapy in rectal cancer.
@en
P2093
Bela Teleky
Carmen Ludwig
Daniela Kandioler
Elisabeth Janschek
Friedrich Herbst
Friedrich Hofbauer
Friedrich Wrba
Irene Kührer
Josef Karner
Judith Karner-Hanusch
P304
P356
10.1097/00000658-200204000-00006
P407
P577
2002-04-01T00:00:00Z